Wayne M. Geissler
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Peptidase Inhibition and Analysis, Diabetes Treatment and Management, Carbohydrate Chemistry and Synthesis, Hormonal and reproductive studies
Most-Cited Works
- → Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3(1994)573 cited
- → Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity(1993)438 cited
- → Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization(2020)120 cited
- → Inhibition of rat α-reductases by finasteride: Evidence for isozyme differences in the mechanism of inhibition(1997)105 cited
- → The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1(2001)84 cited
- → Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors(2003)64 cited
- → Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency.(1996)59 cited
- → The molecular biology of androgenic 17β-hydroxysteroid dehydrogenases(1995)54 cited
- → Design and Synthesis of Prolylcarboxypeptidase (PrCP) Inhibitors To Validate PrCP As A Potential Target for Obesity(2010)51 cited
- → Allosteric Effects of Dexamethasone and RU486 on Glucocorticoid Receptor-DNA Interactions(2002)49 cited